Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Sadif Analytics Prime
$10.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Koninklijke Philips NV Announces FDA Clearance For Alluraclarity Interventional X-Ray System


Wednesday, 3 Jul 2013 08:00am EDT 

Koninklijke Philips NV announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its AlluraClarity live image guidance system in the US. In close collaboration with clinicians in the field of minimally-invasive medicine, Philips has been driving innovation in interventional imaging for more than 50 years, helping to guide procedures such as the catheter-based treatment of obstructed coronary arteries, brain aneurysms, heart rhythm disorders and defective heart valves (heart valve replacement). 

Company Quote

29.06
-0.22 -0.75%
19 Dec 2014